封面
市場調查報告書
商品編碼
2112659

全球基因檢測市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Genetic Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 233 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球基因檢測市場預計將從2025年的168.4億美元成長至2034年的1,060億美元,2026年至2034年的複合年成長率(CAGR)為22.68%。全球基因檢測市場正經歷強勁成長,這主要得益於人們對個人化醫療和疾病早期檢測需求的不斷成長。基因檢測透過分析DNA來識別遺傳性疾病、基因突變和潛在的健康風險。這些檢測廣泛應用於遺傳性疾病的診斷、癌症風險評估、產前篩檢和祖源分析。

基因組學,特別是次世代定序的進步,顯著提高了基因檢測的速度和準確性。醫療服務提供者擴大利用基因數據來製定針對性的治療方案並預測疾病風險。預防醫學意識的提高和基因檢測服務可近性的增強也促進了市場擴張。

未來,隨著精準醫療的普及,基因檢測市場預計將快速成長。基因組研究投入的增加和定序成本的降低將使基因檢測更加普及。隨著醫療體系越來越重視個人化醫療,基因檢測將成為現代醫學不可或缺的一部分。

我們的報告經過精心撰寫,旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分,旨在幫助您全面了解市場環境:

市場概覽:本節對市場進行了清晰的說明,包括關鍵定義、分類以及當前行業格局的概述。

市場動態:對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析:本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局:我們對主要市場參與企業進行了詳細評估,包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測:本部分提供基於數據的市場規模和成長模式預測,預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析,以識別預期的未來趨勢。

區域分析:本部分全面回顧了主要地理區域的市場表現,並識別出高成長領域和區域趨勢,從而更深入地了解特定區域的市場機會。

新趨勢與新機會:識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項:我們提供靈活的報告客製化服務,以滿足您的特定需求。這包括額外的細分、國家/地區特定分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察,以更好地支援您的策略決策。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球基因檢測市場:依技術分類

  • 市場分析、洞察與預測
  • 次世代定序
  • 陣列技術
  • 基於PCR方法的檢測
  • 螢光原位雜合反應
  • 其他

第5章 全球基因檢測市場:依應用領域分類

  • 市場分析、洞察與預測
  • 祖先和人民
  • 性狀篩檢
  • 遺傳疾病的帶因者狀態

第6章:全球基因檢測市場:依新生兒篩檢

  • 市場分析、洞察與預測
  • 健康與保健

第7章 全球基因檢測市場:依產品分類

  • 市場分析、洞察與預測
  • 消耗品
  • 裝置
  • 軟體和服務

第8章 全球基因檢測市場:依通路分類

  • 市場分析、洞察與預測
  • 線上
  • 離線

第9章 全球基因檢測市場:依最終用途分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 診斷檢查室
  • 其他

第10章 全球基因檢測市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第11章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第12章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • 24Genetics
    • Circle DNA
    • Tellmegen
    • 23andMe
    • AncestryDNA
    • MyDNA
    • Everly Well
    • Igenomix
    • VitaGen
    • Myriad Genetics Inc
    • Mapmygenome
    • Helix OpCo LLC
    • MyHeritage Ltd
    • Illumina Inc
簡介目錄
Product Code: VMR112115665

The global genetic testing market size is expected to reach USD 106.00 Billion in 2034 from USD 16.84 Billion in 2025, growing at a CAGR of 22.68% during 2026-2034.The global genetic testing market is witnessing strong growth due to the increasing demand for personalized medicine and early disease detection. Genetic testing analyzes DNA to identify inherited conditions, genetic mutations, and potential health risks. These tests are widely used for diagnosing genetic disorders, cancer risk assessment, prenatal screening, and ancestry testing.

Advances in genomic technologies, particularly next-generation sequencing, have significantly improved the speed and accuracy of genetic testing. Healthcare providers are increasingly using genetic data to develop targeted treatment plans and predict disease susceptibility. The growing awareness of preventive healthcare and expanding access to genetic testing services are also contributing to market expansion.

In the future, the genetic testing market is expected to grow rapidly as precision medicine becomes more widely adopted. Increased investments in genomic research and declining sequencing costs will make genetic testing more accessible. As healthcare systems focus more on personalized treatments, genetic testing will become an essential component of modern medicine.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Technology

  • Next Generation Sequencing
  • Array Technology
  • PCR-based Testing
  • FISH
  • Others

By Application

  • Ancestry & Ethnicity
  • Traits Screening
  • Genetic Disease Carrier Status
  • New Baby Screening
  • Health and Wellness

By Product

  • Consumables
  • Equipment
  • Software & Services

By Channel

  • Online
  • Offline

By End Use

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

COMPANIES PROFILED

  • 24Genetics, Circle DNA, Tellmegen, 23andMe, AncestryDNA, MyDNA, Everly Well, Igenomix, VitaGen, Myriad Genetics Inc., Mapmygenome, Helix OpCo LLC, MyHeritage Ltd., Illumina Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENETIC TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Next Generation Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Array Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. PCR-based Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. FISH Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENETIC TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Ancestry & Ethnicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Traits Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Genetic Disease Carrier Status Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENETIC TESTING MARKET: BY NEW BABY SCREENING 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast New Baby Screening
  • 6.2. Health and Wellness Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENETIC TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Product
  • 7.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENETIC TESTING MARKET: BY CHANNEL 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Channel
  • 8.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Offline Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL GENETIC TESTING MARKET: BY END USE 2022-2034 (USD MN)

  • 9.1. Market Analysis, Insights and Forecast End Use
  • 9.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL GENETIC TESTING MARKET: BY REGION 2022-2034 (USD MN)

  • 10.1. Regional Outlook
  • 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.2.1 By Technology
    • 10.2.2 By Application
    • 10.2.3 By New Baby Screening
    • 10.2.4 By Product
    • 10.2.5 By Channel
    • 10.2.6 By End Use
    • 10.2.7 United States
    • 10.2.8 Canada
    • 10.2.9 Mexico
  • 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.3.1 By Technology
    • 10.3.2 By Application
    • 10.3.3 By New Baby Screening
    • 10.3.4 By Product
    • 10.3.5 By Channel
    • 10.3.6 By End Use
    • 10.3.7 United Kingdom
    • 10.3.8 France
    • 10.3.9 Germany
    • 10.3.10 Italy
    • 10.3.11 Russia
    • 10.3.12 Rest Of Europe
  • 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.4.1 By Technology
    • 10.4.2 By Application
    • 10.4.3 By New Baby Screening
    • 10.4.4 By Product
    • 10.4.5 By Channel
    • 10.4.6 By End Use
    • 10.4.7 India
    • 10.4.8 Japan
    • 10.4.9 South Korea
    • 10.4.10 Australia
    • 10.4.11 South East Asia
    • 10.4.12 Rest Of Asia Pacific
  • 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.5.1 By Technology
    • 10.5.2 By Application
    • 10.5.3 By New Baby Screening
    • 10.5.4 By Product
    • 10.5.5 By Channel
    • 10.5.6 By End Use
    • 10.5.7 Brazil
    • 10.5.8 Argentina
    • 10.5.9 Peru
    • 10.5.10 Chile
    • 10.5.11 Rest of Latin America
  • 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.6.1 By Technology
    • 10.6.2 By Application
    • 10.6.3 By New Baby Screening
    • 10.6.4 By Product
    • 10.6.5 By Channel
    • 10.6.6 By End Use
    • 10.6.7 Saudi Arabia
    • 10.6.8 UAE
    • 10.6.9 Israel
    • 10.6.10 South Africa
    • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

  • 11.1. Recent Developments
  • 11.2. Company Categorization
  • 11.3. Supply Chain & Channel Partners (based on availability)
  • 11.4. Market Share & Positioning Analysis (based on availability)
  • 11.5. Vendor Landscape (based on availability)
  • 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL GENETIC TESTING INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Company Profiles
    • 12.2.1 24Genetics
    • 12.2.2 Circle DNA
    • 12.2.3 Tellmegen
    • 12.2.4 23andMe
    • 12.2.5 AncestryDNA
    • 12.2.6 MyDNA
    • 12.2.7 Everly Well
    • 12.2.8 Igenomix
    • 12.2.9 VitaGen
    • 12.2.10 Myriad Genetics Inc
    • 12.2.11 Mapmygenome
    • 12.2.12 Helix OpCo LLC
    • 12.2.13 MyHeritage Ltd
    • 12.2.14 Illumina Inc